Nuh Kumru, Saliha Yarimoglu, Tayfun Et, Rafet Yarımoglu, Muhammet Korkusuz
{"title":"静脉注射免疫球蛋白治疗重症Covid-19病例报告","authors":"Nuh Kumru, Saliha Yarimoglu, Tayfun Et, Rafet Yarımoglu, Muhammet Korkusuz","doi":"10.5222/jarss.2021.32032","DOIUrl":null,"url":null,"abstract":"Although the treatment of the hyperinflammatory response due to COVID-19 has not yet been found, high-dose corticosteroids, interleukin receptor blockers and intravenous immunoglobulin (IVIG) are used to improve the hyperinflammatory response.In this article, we aimed to share our experiences with 3 patients who received IVIG therapy in ICU.","PeriodicalId":36000,"journal":{"name":"Anestezi Dergisi","volume":"36 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use Of Intravenous Immunoglobulin For The Treatment Of Severe Covid-19: Case Presentation For Three Patients\",\"authors\":\"Nuh Kumru, Saliha Yarimoglu, Tayfun Et, Rafet Yarımoglu, Muhammet Korkusuz\",\"doi\":\"10.5222/jarss.2021.32032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although the treatment of the hyperinflammatory response due to COVID-19 has not yet been found, high-dose corticosteroids, interleukin receptor blockers and intravenous immunoglobulin (IVIG) are used to improve the hyperinflammatory response.In this article, we aimed to share our experiences with 3 patients who received IVIG therapy in ICU.\",\"PeriodicalId\":36000,\"journal\":{\"name\":\"Anestezi Dergisi\",\"volume\":\"36 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anestezi Dergisi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5222/jarss.2021.32032\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anestezi Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5222/jarss.2021.32032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
The Use Of Intravenous Immunoglobulin For The Treatment Of Severe Covid-19: Case Presentation For Three Patients
Although the treatment of the hyperinflammatory response due to COVID-19 has not yet been found, high-dose corticosteroids, interleukin receptor blockers and intravenous immunoglobulin (IVIG) are used to improve the hyperinflammatory response.In this article, we aimed to share our experiences with 3 patients who received IVIG therapy in ICU.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
